Does BINIMETINIB Cause Carcinoembryonic antigen increased? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Carcinoembryonic antigen increased have been filed in association with BINIMETINIB (MEKTOVI). This represents 0.1% of all adverse event reports for BINIMETINIB.
5
Reports of Carcinoembryonic antigen increased with BINIMETINIB
0.1%
of all BINIMETINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Carcinoembryonic antigen increased From BINIMETINIB?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Carcinoembryonic antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BINIMETINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BINIMETINIB Cause?
Off label use (902)
Death (719)
Nausea (657)
Fatigue (562)
Diarrhoea (521)
Product use in unapproved indication (508)
Pyrexia (490)
Neoplasm progression (387)
Vomiting (375)
Rash (360)
What Other Drugs Cause Carcinoembryonic antigen increased?
RIBOCICLIB (143)
LETROZOLE (115)
CAPECITABINE (113)
FULVESTRANT (105)
BEVACIZUMAB (102)
REGORAFENIB (91)
OXALIPLATIN (88)
OSIMERTINIB (82)
PALBOCICLIB (78)
FLUOROURACIL (71)
Which BINIMETINIB Alternatives Have Lower Carcinoembryonic antigen increased Risk?
BINIMETINIB vs BIOFLAVONOIDS
BINIMETINIB vs BIOTIN
BINIMETINIB vs BIPERIDEN
BINIMETINIB vs BIRCH TRITERPENES
BINIMETINIB vs BISACODYL